HTG Molecular Diagnostics, Inc. 2014 Equity Incentive Plan Option Agreement (Inducement Award)Option Agreement • May 9th, 2019 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Option Agreement, HTG Molecular Diagnostics, Inc. (the “Company”) has granted you an option under its 2014 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. The option is granted to you effective as of the date of grant set forth in the Grant Notice (the “Date of Grant”). If there is any conflict between the terms in this Option Agreement and the Plan, the terms of the Plan will control. Capitalized terms not explicitly defined in this Option Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.
Amendment No. 4 to Statement of Work No. TwoStatement of Work • May 9th, 2019 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments
THIS AMENDMENT No. 4 (hereinafter “Amendment 4”) to Statement of Work No. Two is effective as of February 05, 2019 (the “Amendment 4 Effective Date”) by and between HTG Molecular Diagnostics, Inc. (“HTG”) and QIAGEN Manchester Limited (“QIAGEN”).
FIRST AMENDMENT TO AMENDED AND RESTATEDIvd Test Development and Component Supply Agreement • May 9th, 2019 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments
This First Amendment to Amended and Restated IVD Test Development and Component Supply Agreement (the “Agreement”) is effective as of April 3, 2019 (the “Amendment Effective Date”) and is made by and between Illumina, Inc., a Delaware corporation having a place of business at 5200 Illumina Way, San Diego, California 92122, (“Illumina”) and HTG Molecular Diagnostics, Inc., a Delaware corporation having a place of business at 3430 E Global Loop, Tucson, Arizona 85706 (“Company”). Illumina and Company may also individually be referred to herein as a “Party” and collectively as the “Parties.”
HTG Molecular Diagnostics, Inc. 2014 Equity Incentive Plan Option Agreement (Incentive Stock Option or Nonstatutory Stock Option)Option Agreement • May 9th, 2019 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Option Agreement, HTG Molecular Diagnostics, Inc. (the “Company”) has granted you an option under its 2014 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. The option is granted to you effective as of the date of grant set forth in the Grant Notice (the “Date of Grant”). If there is any conflict between the terms in this Option Agreement and the Plan, the terms of the Plan will control. Capitalized terms not explicitly defined in this Option Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.
